5th Clinical Trials Phase I and Phase IIA Summit

Conference themes
Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase two proof-of-concept and dose range finding studies are vital to effectively designing future registration studies.

Professional congress organizer (PCO)
Exl Events

https://go.evvnt.com/260469-1?pid=4832

Ms. Gina DeMarco